EARNING RECAP

Micron Technology Inc

#MU 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q2 $1.71 est. $1.67 $5.84B est. $5.82B +9.62% ($43.99 closing price) $44.21 $41.65 sees Q3 EPS 85c (+/- 10c) est. $1.23; sees Q3 revenue $4.8B +/- $200M est. $5.33B
Q1 $2.97 est. $2.96 $7.91B est. $8.02B -7.92% ($31.41 closing price) $33.58 $31.27 Stock price hits 1 year low; Lowers Fy19 DRAM industry demand to 16% from 20%; sees Q2 EPS $1.75+/- 10c est. $2.44, sees Q2 revenue $5.7B-$6.3B est. $7.34B
#MU 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $3.53 est. $3.34 $8.44B est. $8.25B -2.87% ($44.74 closing) $45.60 $43.80 Q4 cash flow $5.16B vs. $3.2B last year; record revenue in Fy18; says Q1 gross margin will be lower than Q4 due to tariffs on supply; sees Q1 EPS $2.95 +/- 7c est. $3.06
Q3 $3.15 est. $3.12 $7.8B est. $7.75B +.83% ($59.44 closing) $61.83 $59.44 Sees Q4 GM 59%- 62%; Q3 represents-DRAM represents 71% of revenue; NAND 25%
Q2 $2.82 est. $2.74 $7.35B est. $7.28B -7.99% ($54.21 closing) $58.80 $53.68 says secular technology trends driving robust demands* Q2 CF $4.3B FCF $2.2B; guides Q3 EPS $2.83, +/- 7c est. $2.63, revenue $7.20B -$7.6B, est. $7.27B
Q1 $2.45 vs $2.19 $6.8B vs $6.41B +4.02% ($45.75 closing price) $46.80 $44.86
#MU 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $2.02 Vs $1.84 $6.14B Vs $5.96B +8.51% $37.15 $35.92 Says Q4 margin increase due to DRAM products

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.